Reset
Showing 11 of 31 academic articles

Current Evidence on Gene-Based and Epigenetic Therapeutic, Diagnostic, and Prognostic Strategies in Epithelial-Derived Carcinomas: A Scoping Review

Joshua George Thomas, Mohammed Ayyub, Lovely M. Annamma, Prathibha Prasad et al. • Biomedicines (2026)

Background: Epithelial-derived carcinomas exhibit genomic instability due to genetic mutation and epigenetic dysregulation. Mechanisms such as DNA methylation, histone modifications, and noncoding RNA regulation may lead to tumor progressio...

DOAJ Open Access (DOAJ) DOI: 10.3390/biomedicines14102234

A renaissance of neural networks in drug discovery

Igor I. Baskin, David Alan Winkler, Igor V. Tetko • Expert Opinion on Drug Discovery (2016)

INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to cho...

OPENALEX DOI: https://doi.org/10.1080/17460441.2016.1201262

DNA methylation patterns of circadian and ultradian genes are altered in the peripheral blood of patients with hidradenitis suppurativa

Uppala Radhakrishna, Uppala Ratnamala, Devendrasinh D. Jhala, Lavanya V. Uppala et al. • Frontiers in Immunology (2024)

BackgroundHidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects hair follicles in areas with apocrine sweat glands, such as the underarms, groin, and buttocks. The pathogenesis of HS is not fully understood, bu...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2024.1475424

Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances

Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal (2023)

Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.bj.2023.100633

Deep learning improves antimicrobial peptide recognition

Daniel Veltri, Uday Kamath, Amarda Shehu • Bioinformatics (2018)

Motivation: Bacterial resistance to antibiotics is a growing concern. Antimicrobial peptides (AMPs), natural components of innate immunity, are popular targets for developing new drugs. Machine learning methods are now commonly adopted by w...

OPENALEX cc-by-nc DOI: https://doi.org/10.1093/bioinformatics/bty179 PMC: 6084614

Knowledge-transfer learning for prediction of matrix metalloprotease substrate-cleavage sites

Yanan Wang, Jiangning Song, Tatiana T. Marquez-Lago, André Leier et al. • Scientific Reports (2017)

Abstract Matrix Metalloproteases (MMPs) are an important family of proteases that play crucial roles in key cellular and disease processes. Therefore, MMPs constitute important targets for drug design, development and delivery. Advanced pro...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-017-06219-7

Prediction of Drug Targets for Specific Diseases Leveraging Gene Perturbation Data: A Machine Learning Approach

Kai Zhao, Yujia Shi, Hon-Cheong So • Pharmaceutics (2022)

Identification of the correct targets is a key element for successful drug development. However, there are limited approaches for predicting drug targets for specific diseases using omics data, and few have leveraged expression profiles fro...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14020234

Machine learning and applications in microbiology

Stephen J. Goodswen, Joel Barratt, Paul J Kennedy, Alexa Kaufer et al. • FEMS Microbiology Reviews (2021)

To understand the intricacies of microorganisms at the molecular level requires making sense of copious volumes of data such that it may now be humanly impossible to detect insightful data patterns without an artificial intelligence applica...

OPENALEX cc-by-nc DOI: https://doi.org/10.1093/femsre/fuab015 PMC: 8498514

Artificial intelligence in cancer target identification and drug discovery

Yujie You, Xin Lai, Yi Feng Pan, Huiru Zheng et al. • Signal Transduction and Targeted Therapy (2022)

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems ...

OPENALEX cc-by DOI: https://doi.org/10.1038/s41392-022-00994-0 PMC: 9090746

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies

Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine (2026)

Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12967-026-07966-w